Tübingen, Germany

Klaus Schulze-Osthoff

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet. Active years: 2017.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Klaus Schulze-Osthoff: Innovator in Cell Senescence Visualization

Introduction

Klaus Schulze-Osthoff is a notable inventor based in Tübingen, Germany. He has made significant contributions to the field of cell biology, particularly in the visualization of cell senescence. His innovative work has led to the development of novel compounds that are essential for advancing research in this area.

Latest Patents

Klaus Schulze-Osthoff holds 1 patent related to his invention titled "Senescence tracers." This patent focuses on novel compounds that are useful for visualizing cell senescence. The invention specifically relates to fucose and amino-quinoline derivatives that serve as senescence tracers, along with their preparation and application.

Career Highlights

Throughout his career, Klaus has been associated with prestigious institutions, including the Eberhard Karls University of Tübingen, specifically within the Medical Faculty. His work at this university has allowed him to explore and develop innovative solutions in the field of cell biology.

Collaborations

Klaus has collaborated with notable colleagues such as Jonathan Cotton and Anna Teske. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Klaus Schulze-Osthoff's contributions to the field of cell senescence visualization through his innovative patents highlight his role as a significant inventor. His work continues to influence research in cell biology and related fields.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…